← SynDRA
OLMESARTAN MEDOXOMIL
SynDRA canonical compound SYN0023132 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | AGTR1 |
| Mechanism of action | Angiotensin receptor antagonist |
| Indication | hypertension |
| Disease area | cardiology |
All known targets
Mechanisms of action (all sources)
- Angiotensin receptor antagonist
- AGTR1 ANTAGONIST
- Type-1 angiotensin II receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABCB11
- ABCC3
- SLCO1B3
- SLCO1B1
- PDE4D
- HTR7
- NPY1R
- MLNR
- MC4R
- MC3R
- MAOA
- KCNH2
- HTR3A
- HTR6
- NR3C1
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- HRH2
- HRH1
- NPY2R
- OPRD1
- NTSR1
- SLC29A1
- TBXA2R
- TACR1
- SLCO2B1
- SLC6A4
- SLC6A3
- SLC6A2
- SAMHD1
- GIPR
- PTGS2
- PPARG
- PGR
- PDE3A
- OPRM1
- OPRK1
- HDAC6
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Angiotensin 2 Receptor Antagonists
- Angiotensin 2 Receptor Blocker
- Angiotensin II Type 1 Receptor Blockers
- Angiotensin Receptor Antagonists
- Antihypertensive Agents
- Cardiovascular Agents
ATC classes
- C09C · ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN
- ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
Cross-references
Synonyms
- AMLODIPINE AND OLMESARTAN MEDOXOMIL
- AZOR
- BENICAR
- BENICAR HCT
- OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
- OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE
- TRIBENZOR
- olmetec
- CS-866
- CS866
- Olmesartan medoxomilo
- NSC-758924
- Benicar
- Olmesartan medoxomil component of azor
- Olmesartan medoxomil component of benicar hct
- Olmesartan medoxomil component of tribenzor
- Olmetec
- Benevas
- Olvance
- Forest Brand of Olmesartan Medoxomil
- Olmesartan medoximil
- Sankyo Brand of Olmesartan Medoxomil
- Benicar (TN)
- Berlin-Chemie Brand of Olmesartan Medoxomil
- CS-866DM
- CS-866RN
- DE-092
- KS-1182
- Olmetec (TN)
- Benicar, Olmetec,Olmesartan
- Olmesartan medoxomil (JAN/USAN)
- olmesartan-medoxomil
- Cs 866
- olmesartan medoxomil (usp monograph)
- olmesartan medoxomil (usp-rs)
- TRIBENZOR COMPONENT OLMESARTAN MEDOXOMIL
Reported adverse events
- Hypotension
- Vomiting
- Angioedema
- Rhabdomyolysis
- Asthenia
- Alopecia
- Dizziness
- Nausea
- Hypersensitivity
- Hypertension
- Myopia
- Syncope
Look up OLMESARTAN MEDOXOMIL in the interactive SynDRA portal →